Optimal therapeutic approaches to femoropopliteal artery intervention

Catheterization and Cardiovascular Interventions

Volumn 63, Issue 1, 2004, Pages 21-30

  Das, Tony ^a  

^a CIMA Vascular Group   (United States)

Author keywords

Cross Point SafeCross; Cryotherapy; Laser; PTA; Silverhawk; Stent; Superficial femoral artery; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANTICOAGULANT AGENT; CILOSTAZOL; CLOPIDOGREL; DIPYRIDAMOLE; FIBRINOLYTIC AGENT; NITINOL; PENTOXIFYLLINE; POLITEF; PROUROKINASE; RETEPLASE; STREPTOKINASE; TENECTEPLASE; TICLOPIDINE; UROKINASE;

ARTERY DISEASE; ARTERY OCCLUSION; BRACHYTHERAPY; CATHETER; CLINICAL TRIAL; DIRECTIONAL ATHERECTOMY; ENDOVASCULAR SURGERY; EXCIMER LASER; FEMOROPOPLITEAL ARTERY; FIBRINOLYTIC THERAPY; GUIDE WIRE; HUMAN; INTERMITTENT CLAUDICATION; INTERVENTIONAL RADIOLOGY; KINESIOTHERAPY; LIFESTYLE; LIMB ISCHEMIA; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POPLITEAL ARTERY; REVIEW; STENT; SUPERFICIAL FEMORAL ARTERY; THROMBOSIS; WALKING;

ARTERIAL OCCLUSIVE DISEASES; EXERCISE THERAPY; FEMORAL ARTERY; FIBRINOLYTIC AGENTS; HUMANS; ISCHEMIA; LOWER EXTREMITY; PLATELET AGGREGATION INHIBITORS; POPLITEAL ARTERY; RADIOTHERAPY, COMPUTER-ASSISTED; STENTS; VASCULAR SURGICAL PROCEDURES;

EID: 4444288602     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.20063     Document Type: Review

References (50)

1. Lundgren F, Dahllof AF, Lundholm K, Shersten T, Volkmann T. Intermittenent claudication-surgical reconstruction or physical training? Ann Surg 1989;209:346-355.
2. Creasy TS, McMillan PJ, Fletcher EW, Collin J, Morris PJ. Is percutaneous transluminal angioplasty better than exercise for claudication? preliminary results of a prospective randomized trial. Eur J Vasc Surg 1990;4:135-140.
3. Perkins JM, Collin J, Creasy TS, et al. Exercise training vs. angioplasty for stable claudication: long- and medium-term results of a randomized trial. Eur J Vasc Endovasc Surg 1996;11:409-413.
4. Williams LR. Vascular rehabilitation: benefits of a structured exercise/risk modification program. J Vasc Surg 1991;14:320.
5. Ernest E, Fialka V. A review of the clinical effectiveness of exercise therapy for intermittent claudication: indications, methods and results. Sugery 1978;84:640-643.
6. Porter JM, Baur GM. Pharmacologic treatment of intermittent claudication. Sugery 1982;92:966-971.
7. Hood SC, Moher D, Barber GG. Management of intermittent claudication with pentoxyphylline: meta-analysis of randomized controlled trials. CMAJ 1996;155:1053-1059.
8. Jackson MR, Clagett GP. Antithrombotic therapy in peripheral arterial occlusive disease. Chest 1998;114:666S-682S.
9. Dawson DL, Beebe HG, Davidson MH, et al. Comparison of medical interventions for treating intermittent claudication. Am J Med 2000;109:523-530.
10. Byrne J, Darling C, Chang B, et al. Infrainguinal arterial reconstruction for claudication: is it worth the risk? An analysis of 409 procedures. J Vasc Surg 1999;29:259-269.
11. Wengeter KR, Veith FJ, Gupta SK, et al. Prospective randomized multi-center comparison of in situ and reversed vein infrapopliteal bypasses. J Vasc Surg 1991;13:189-199.
12. Schwartz ME, Harrington EB, Schanzer J. Wound complications after in situ bypass: analysis of risk factors. Ann Vasc Surg 1988:7:802-807.
13. Dalman RL, et al. Basic data in clinical decision making in vascular surgery. Infrainguinal Revasc Proc 1994.
14. Muluk SC, Muluk SV, Kelley ME, et al. Outcome events in patients with claudication: a 15 year study in 2777 patients. J Vasc Surg 2001;33:251-258.
15. Wolf GL, et al. Surgery or balloon angioplasty for peripheral vascular disease: a randomized clinical trial. J Vasc Interv Radiol 1993;4:639-644.
16. Ouriel K, Shortell CK, DeWeese JA, et al. The Rochester trial: a comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia. J Vasc Surg 1994;19:1021-1030.
17. STILE investigators. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower ischemia: the STILE trial. Ann Surg 1994;220:251-268.
18. Ouriel K, Veith FJ, Sasahara AA. TOPAS 2 trial: a comparison of recombinant urokinase with vascular surgery as initial treatment of acute arterial occlusions of the leg. N Engl J Med 1998;338:1105-1111.
19. Kiproff PM, Yammine K, Potts JM, Nahum E. Reteplase infusion in the treatment. J Thromb Thrombo 2002; 13:75-79.
20. Razavi MK, Wong H, Kee ST, Sze DY, Semba CP, Dake MD. Initial clincal results of tenecteplase (TNK) in catheter-directed thombolytic therapy. J Endovasc Ther 2002;9:593-598.
21. Capek P, McClean GK, Berkowitz HD. Femoropopliteal angioplasty: factors influencing long-term success. Circulation 1991; 83(Suppl 1):70-80.
22. Johnston KW. Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. Radiology 1992;183:767-771.
23. Matsi PJ, Manninen HI, Vanninen RL, et al. Femoropopliteal angioplasty in patients with claudication: primary and secondary patency in 140 limbs with 1-3 year follow-up. Radiology 1994; 191:727-733.
24. Hunink MG, Donaldson MC, Meyerovitz MF, et al. Risks and benefits of femoropopliteal percutaneous balloon angioplasty. J Vasc Surg 1993;17:183-194.
25. Hunicnk MG, Wong JR, Donaldson MC, et al. Patency results of Percutaneous and surgical revascularization for femoropopliteal arterial disease. Med Decision Making 1994;14:71-81.
26. Johnston KW. Femoral and popliteal arteries: re-analysis of results of balloon angioplasty. Radiology 1992;183:767-771.
27. Kandarpa K, Becker GJ, Ferguson RD, Connors JJ 3rd, Wojak JC, Landow WJ. Transcatheter interventions for the treatment of peripheral atherosclerotic lesions: part II. J Vasc Interv Radiol 2001;12:807-812.
28. Chatelard P, Gurbourt C. Long-term results with a Palmaz stent in the femoropopliteal arteries. J Cardiovasc Surg 1996;37:67-72.
29. Martin EC, Katzen BT, et al. Multicenter trial of the wallstent in the iliac and femoral arteries. J Vasc Interv Radiol 1995;6:843-849.
30. Ansel GM, Botti CF, et al. Clinical results for the training phase roll-in patients in the IntraCoil femoropopliteal stent trial. Catheter Cardiovasc Interv 2002;556:443-449.
31. Ahmadi R, Schillinger M, et al. Femoropopliteal arteries: immediate and long-term results with a Dacron-covered stent graft. Radiology 2002;223:345-350.
32. Lammer J, Dake M, et al. Peripheral arterial obstruction: prospecitve study of treatment with a transluminally placed self-expanding stent graft. Radiology 2000;217:95-105.
33. Mewissen MW. Nitinol stents in the femoropopliteal aterial segment. Endovass Today 2003;4:29-34.
34. Scheinert D. Nitinol stent use in long SFA disease. Paris: Paris Course on Revascularization; 2003.
35. Duda SH, Pusich B, Richter G, et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery diease: six month results. Circulation 2002;106:505-509.
36. Duda SH. SIRROCCO 1 and 2 results: Late breaking trials. Washington, DC: Transcatheter Therapeutics 2003.
37. Scheinert D, Laird JR, et al. Excimer laser-assisted recanalization of long, chronic superficial femoral artery occlusions. J Endovascular Ther 2001;8:156-166.
38. Kim D, Gianturco LE, Porter DH, Orron DE, Kuntz RE, Kent KC, Siegel JB, Schlam BW, Skillman JJ. Peripheral directional atherectomy: 4-year experience. Radiology 1992;183:773-778.
39. Laird JR. Interim analysis of the Cryo Vascular peripheral balloon catheter system safety registry. Society of Interventional Radiology; Salt Lake City, Utah. 2003.
40. Laird JR. Big chill registry data presentation. Las Vegas: VIVA Meeting; 2003.
41. Waksman R, Laird JR, Jurkovitz CT, et al. Intravascular radiation therapy after balloon angioplasty of narrowed femopopliteal arteries to prevent restenosis: results of the PARIS feasibility trial. J Vasc Interv Radiol 2001;12:915-921.
42. Reinenger C, Graf J. Reninger A, Spannagl M, Steckmeier B, Schweiberer L. Increased platelet and coagulatory activity indicate ongoing thrombogenesis in peripheral arterial disease. Thromb Res 1996;82:523-532.
43. Heiss HW, Just H, Middleton D, Deischsel G. Reocclusion prophylaxis with dipyridamole combined with acetylsalicylic acid following PTA. Angiology 1990;41:263-269.
44. Study Group on Pharmacologic Therapy After PTA. Platelet inhibition with ASA/dipyridamole after percutaneous balloon angioplasty in patients with symptomatic lower limb arterial disease: a prospective double-blind trial. Eur J Vasc Surg 1994;8:83-88.
45. Minar E, Ahmadi A, Koppensteiner R, et al. Comparison of effects of high-dose and low-dose aspirin on restenosis after femoropopliteal percutaneous transluminal angioplasty. Circulation 1995;91:2167-2173.
46. Weichert W, Meents H, Abt K, et al. Acetylsalicylic acid-reocclusion- prophylaxis after angioplasty (ARPA study). Vasa 1994; 23:57-65.
47. Do DD, Mahler F. Low-dose aspirin combined with dipyridamole versus anticoagulants after femoropopliteal percutaneous angioplasty. Radiology 1994;193:567-571.
48. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-1339.
49. Girolami B, Bernardi E, Prins MH, tenCate JW, Prandoni P, Simioni P, Andreozzi GM, Girolami A, Buller HR. Antiplatelet therapy and other interventions after revascularization procedures in patients with peripheral arterial disease: a meta-analysis. Eur Vasc Endovasc Surg 2000;19:370-380.
50. TransAtlantic Inter-Society Consensus (TASC) Working Group. Management of peripheral arterial occlusive disease: TASC document. J Vasc Surg 2000;31(Suppl):S1-S27.